Chilton Capital Management LLC Astrazeneca PLC Transaction History
Chilton Capital Management LLC
- $2.19 Billion
- Q2 2024
A detailed history of Chilton Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Chilton Capital Management LLC holds 326,505 shares of AZN stock, worth $26 Million. This represents 1.17% of its overall portfolio holdings.
Number of Shares
326,505
Previous 331,454
1.49%
Holding current value
$26 Million
Previous $22.5 Million
13.4%
% of portfolio
1.17%
Previous 1.09%
Shares
25 transactions
Others Institutions Holding AZN
# of Institutions
1,333Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.17 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.39 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.23 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.92 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.4 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $247B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...